9th Annual Biomarkers Congress

Oncology: University of Texas, MD Anderson

Total Score People Score Events Score
117 89 50
Date Event Presentation Speakers
April 11, 2014 6th Annual Asian Oncology Summit and 10th Annual Conference of the Organisation for Oncology and Translational Research (OOTR) 6th Annual Asian Oncology Summit and 10th Annual Conference of the Organisation for Oncology and Translational Research (OOTR) Rakesh Kumar
March 19, 2014 3rd Neurological Biomarkers Chairperson's Introduction Andreas Jeromin
October 28, 2013 Tumor Immunology and Immunotherapy TNFalpha and TLR3/4 induced necrosis pathway Xiaodong Wang
May 31, 2013 ASCO Annual Meeting 2013 Management of Chronic Lymphocytic Leukemia (M10) William G. Wierda
Education Sessions Anas Younes
Education Sessions John de Groot
Special Session Razelle Kurzrock, Gabriel N Hortobagyi
Education Sessions Robert L. Coleman
Educations Sessions Jeffrey E Gershenwald, Stanley Hamilton
April 6, 2013 AACR Annual Meetings Drug Discovery in Industry, Academia, and Government: What Is the Track Record? Michael A. White
Clinical Trial Design in the Genomic Era Co-Chairpersons: Donald A. Berry, The University of Texas MD Anderson Cancer Center, Houston, TX, and George W. Sledge, Jr., Stanford University School of Medicine, Stanford, CA Donald Berry
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Gordon Mills
Bridging the Gap Between Clinical Research and Laboratory Investigation: Utilizing Presurgical Clinical Trials to Investigate Anti-CTLA-4 Immunotherapy Padmanee Sharma, The University of Texas MD Anderson Cancer Center, Houston, TX Padmanee Sharma
Whole Body Metabolism and Cancer Chairperson: Philipp E. Scherer, UT Southwestern Medical Center, Dallas, TX Philipp Scherer
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY George A. Calin
Identifying Novel Redox Signaling Pathways for Cancer Chemoprevention: From Fly to the Mouse Garth Powis, The University of Texas MD Anderson Cancer Center, Houston, TX Garth Powis
PAK Family of Kinases in Human Cancer: Past, Present, and Future Rakesh Kumar, George Washington University, Washington, DC Rakesh Kumar
March 4, 2012 "Cellular Oncology" new insights leading to clinical advancement" "Cellular Oncology" new insights leading to clinical advancement" William F. Symmans
November 18, 2011 16th Annual Perspectives In Thoracic Oncology New insights in the management of mesothelioma Anne Tsao
July 6, 2011 3rd WIN Symposium CONCURRENT WORKSHOPS | Workshop of the WIN Consortium Committee on standardization of biobanking and molecular analyses of biopsies in clinical trials (open to the public) STANLEY HAMILTON, Ignacio I. Wistuba
ROUND TABLE - PANEL OF EXPERTS - FORUM OF OPEN DISCUSSION WITH ATTENDEES | Monotherapies or combined therapeutics? Clinically addressing the complexity of molecular pathways in cancer: How can we develop the most relevant combination beyond individual Pharma/Biotech pipelines: a risk sharing approach for the benefit of the patient JOHN MENDELSOHN
KEYNOTE LECTURE | Challenges and opportunities in personalized cancer therapy and cooperation between the Pharmaceutical Industry and Academia. The WIN Consortium model and operational goals JOHN MENDELSOHN
SESSION 4 | STRATEGIC ALLIANCES TO FIGHT CANCER JOHN MENDELSOHN
Using biomarkers prospectively in adaptive trials Donald Berry
SESSION 7 | STRATEGIES TO IMPROVE EFFICIENCY OF CLINICAL TRIALS Donald Berry
CONCURRENT WORKSHOPS | Workshop of the WIN Consortium Scientific Committee on the design of clinical trials, data processing and access (open to the public) Razelle Kurzrock, Donald Berry
CONCLUSION | THE URGENT NEED FOR INCREASED ACCESS OF PATIENTS FROM DIVERSE POPULATIONS TO INNOVATIVE CLINICAL TRIALS JOHN MENDELSOHN
General Assembly of the WIN Consortium (business meeting, restricted to members and open to non members by request and invitation only) JOHN MENDELSOHN
February 17, 2011 Mayo Clinic World Robotics Symposium in Gynecology Robotic Pelvic Lymphadenectomy Pedro T. Ramirez
Robotic Radical Trachelectomy for Fertility-Preservation Pedro T. Ramirez
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Harnessing the Cell Biology of Dendritic Cells against Cancer (Joint) | Plasmacytoid DC in Cancer Yong-Jun Liu
September 30, 2010 Third AACR Conference on The Science of Cancer Health Disparities Educational Session 2: The Chronic Disease Prevention Model: It's Time to Think Strategically Elisabeth Martinez
Quantitative epigenomics for epidemiology research Jean-Pierre Issa
September 30, 2010 Third AACR Conference on the Science of Cancer Health Disparities in Racial / Ethnic Minorities and the Medically Underserved The Chronic Disease Prevention Model: It's Time to Think Strategically Elisabeth Martinez
Quantitative epigenomics for epidemiology research Jean-Pierre Issa
September 27, 2010 25th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and Metastasis: from Bench to Bedside to Biomarkers Therapy of Cancer Metastasis: Attacking the Stroma Isaiah J. Fidler
The Biology of Cancer Metastasis Isaiah J. Fidler
July 15, 2010 Breast Cancer: Current Controversies | New Horizons Surgery Issues After Preoperative Therapy Funda Meric Bernstam
B. Managing the Extra-Axillary Sentinel Node and Positive Internal Mammary Nodes Funda Meric Bernstam
April 10, 2010 Practical Updates in Oncology Therapeutic Options in Ovarian Cancer Robert L. Coleman
Advances in Chronic Lymphocytic Leukemia William G. Wierda
Targeted Therapies for Gastrointestinal Malignancies Cathy Eng
Treatment Advances in SCLC and NSCLC Joan H Schiller
Lunch/Ethics Lecture Michael S Ewer
February 19, 2010 Eighth International Symposium on Supportive Care in Oncology: Cancer Management in the Era of Targeted Agents Nutrition and Supplements Maria Petzel
Management of Toxicities Associated With Antivascular Agents Michael S Ewer
February 11, 2010 Second Annual Conference The Sixth Vital Sign: What Every Oncologist Should Know About Molecular Oncology: Applications to Patient Care Rare Tumors: A Personalized Therapy Approach With a Case History Razelle Kurzrock
February 11, 2010 5th Annual Symposium on PET/CT and Molecular Imaging Pick Your Poison with Bone Metastases: MDP or FDG? Homer A. Macapinlac
Evaluating Pelvic Tumors Homer A. Macapinlac
Imaging "The Prodigal Tumors": PET and Pancreatic, Hepatic, Small Bowel, Renal, Adrenal, and Metastastic Cancers Homer A. Macapinlac
PET/CT for Infection: Blessing or a Curse Homer A. Macapinlac
January 29, 2010 9th Annual UCSF Clinical Cancer Update TBA Massimo Cristofanilli
January 21, 2010 2010 DERMATOLOGY FOUNDATION CLINICAL SYMPOSIA: ADVANCES IN DERMATOLOGY IV. Surgical Reconstruction: How We Do It Tri H. Nguyen
Surgical Pearls: When Simple is Better Tri H. Nguyen
January 21, 2010 7th Annual Natural Supplements: An Evidence-Based Update A. Diabetes and Metabolic Syndrome: An Integrative Approach Victor Sierpina
November 12, 2009 Sixth International Conference - Revitalizing Cancer Care: Comprehensive Interdisciplinary Programs and Whole Systems Research Keynote Lecture: Whole Systems Research in Integrative Oncology: What is It? Why Do We Need It? Lorenzo Cohen
d. Massage Therapy Sat-Siri Sumler
Theory/Practice Moshe Frenkel
1) Preferred Abstracts (5) Basic Peiying Yang
Whole Systems Into Practice: Summary and Future Visions David I Rosenthal, Moshe Frenkel
November 6, 2009 Translating Scientific Advances Into Clinical Care for Cancer Multiple Myeloma Robert Z. Orlowski
October 2, 2009 13th Annual Fall Oncology Conference: Clinical Challenges in Cancer Medicine State-of-the-Art Treatment in Sarcoma Robert S. Benjamin
PRO Cathy Eng
PRO Robert Coleman
Treatment Options for Patients With Platinum-Sensitive and Platinum-Resistant Recurrent Ovarian Cancer Robert Coleman
Complications of Antiangiogenic Therapy Cathy Eng
October 1, 2009 6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO) Panel Discussion With Interactive Q/A Sushovan Guha
Case Presentation 2: Locally Advanced (Radiotherapy vs. Chemotherapy) Gauri Varadhachary
Panel Discussion With Interactive Q/A Sushovan Guha
A Novel Small Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth In Vivo Sushovan Guha
Prognostic Factors of Rectal and Anal Cancer Outcomes Prajnan Das
Panel Discussion With Interactive Q/A Ju-Seog Lee
Molecular Biology: East and West Ju-Seog Lee
September 24, 2009 Track 3:Advancing Cancer Therapy : Inaugural Circulating Tumor Cells The Clinical Utility of Circulating Tumor Cell Analysis: What Have We Learned So Far? Beverly C. Handy
September 23, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual Adaptive Clinical Trial Designs Personalized Medicine: Using Biomarker Signatures to Predict Response to New Therapies J. Kyle Wathen
June 9, 2009 Cell and Tissue-Based Assays for HTS A Novel Platform for High-Throughput Gene Expression Profiling Andreas Jeromin
February 3, 2009 Cancer Health Disparities PLENARY SESSION 2: INJECTING CULTURE INTO THE ATTACK ON CANCER Amelie G Ramirez
CONCURRENT SESSIONS M Kristen Peek
January 26, 2009 Biomarker Assay Development Circulating Tumor Cell Assays: A Prognostic and Predictive Factor For Breast, Prostate And Colon Cancer Herbert A Fritsche
January 26, 2009 Translational Cancer Medicine Circulating Tumor Cell Assays: A Prognostic and Predictive Factor For Breast, Prostate And Colon Cancer Herbert A Fritsche
January 21, 2009 Advances in Prostate Cancer Research SESSION 3: APOPTOSIS Xiaodong Wang
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Application of New Proteomics Technologies to Drug Discovery : Track 1-3 Yingming Zhao
Title: TBD:Track 2-2 Dihua Yu
Feedstock and Enzyme Improvement for Bioenergy : Track 5-1 Joshua S. Yuan
November 23, 2008 Advanced Technology in Radiation Oncology Inhibition Of XIAP Facilitates TRAIL Induced Apoptosis And Improves Survival In A Bioluminescent Glioma Xenograft Model. Vinay K Puduvalli
November 21, 2008 The 13th Annual Scientific Meeting of the Society for Neuro-Oncology Enzastaurin (ENZ) Versus Lomustine (CCNU) In The Treatment Of Recurrent, Intracranial Glioblastoma (GBM): A Phase III Study. Vinay K Puduvalli
Imaging Glioblastoma Progression During Anti-VEGF Therapy. John de Groot
November 17, 2008 BIO-Europe 2008 Critical Issues to Consider when Entering the U.S. Market and Partnering with U.S. Companies Steve Bryant
November 6, 2008 The 2008 Research Conference on Food, Nutrition, Physical Activity & Cancer Omega-3 Fatty Acids and Cancer Prevention Robert S. Chapkin
October 30, 2008 44th ASCO Annual Meeting General Session IV: Molecular Markers of Response and Resistance to Angiogenesis Inhibitors John Heymach
October 21, 2008 20th EORTC - NCI - AACR Symposium on "Molecular Targets and Cancer Therapeutics" Workshop 1 Animal models in drug development J. L. Abbruzzese
Plenary session 10 Challenges in the development of anti bodies and antibody conjugates Chris H. Takimoto
June 27, 2008 American Society of Clinical Oncology Welcome & Introductions J. L. Abbruzzese
Program Commitee J. L. Abbruzzese, Cathy Eng, Hagop M. Kantarjian
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
cancer genetics-- Single Nucleotide Polymorphisms, Clinical Trials, and Tobacco Research: Search for the Smoking Gun Margaret R. Spitz
cancer prevention/epidemiology-- Single Nucleotide Polymorphisms, Clinical Trials, and Tobacco Research: Search for the Smoking Gun Margaret R. Spitz
cancer prevention/epidemiology-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
developmental therapeutics-- c-MET Inhibition for Cancer Treatment Razelle Kurzrock
developmental therapeutics-- Issues in the Modulation of Angiogenesis Pathways (M10) Roy S. Herbst
developmental therapeutics-- Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
gastrointestinal (colorectal) cancer-- Advances in Anal Cancer Management (M01) Cathy Eng
gastrointestinal (colorectal) cancer-- Intraperitoneal Treatment for Gastrointestinal Cancer: Role of Debulking and Chemotherapy Cathy Eng
gastrointestinal (noncolorectal) cancer-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07A) James C. Yao
gastrointestinal (noncolorectal) cancer-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07B) James C. Yao
gastrointestinal (noncolorectal) cancer-- Intraperitoneal Treatment for Gastrointestinal Cancer: Role of Debulking and Chemotherapy Cathy Eng
gastrointestinal (noncolorectal) cancer Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
genitourinary cancer-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies CPO20A) Paul Mathew
genitourinary cancer What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20B) Paul Mathew
gynecologic cancer-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
lung cancer-- Therapeutic Modalities for “Small” Stage I Lung Cancers Robert Timmerman
lymphoma and plasma cell disorders-- The Role of Maintenance Therapy in Follicular Lymphoma: Pros and Cons Peter McLaughlin
patient and survivor care-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
patient and survivor care-- Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
sarcoma/bone and soft tissue cancers-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
tumor biology-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
meet the professor sessions-- Advances in Anal Cancer Management (M01) Cathy Eng
meet the professor sessions-- Issues in the Modulation of Angiogenesis Pathways (M10) Roy S. Herbst
meet the professor sessions-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
meet the professor sessions-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
meet the professor sessions-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
clinical problems in oncology-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07A) James C. Yao
clinical problems in oncology-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07B) James C. Yao
clinical problems in oncology-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20A) Paul Mathew
clinical problems in oncology-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20B) Paul Mathew
April 27, 2008 Phage Display of Antibodies and Peptides Engineering Aglycosylated Antibodies with Effector Functions George Georgiou
Ligand-Directed Vascular Targeting and Molecular Imaging Renata Pasqualini
March 25, 2008 PATHWAY ANALYSIS Non Coding RNAs Involvement in Cancer Predisposition and Tumor Development George A. Calin
March 25, 2008 CANCER MOLECULAR MARKERS Non Coding RNAs Involvement in Cancer Predisposition and Tumor Development George A. Calin
January 18, 2008 Translational Research Program Stem Cell Symposium Critique/Discussion Wendy Woodward
Circulating Tumor Cells Massimo Cristofanilli
Panel Discussion Luka Milas
November 6, 2007 Chemotherapy Foundation Symposium XXV SECOND & THIRD GENERATION TYROSINE KINASE INHIBITORS in CML Hagop M. Kantarjian
AML IN THE ELDERLY: A PROBLEM WITH SOME SOLUTIONS Hagop M. Kantarjian
UPDATE ON TREATMENT OPTIONS IN MDS AND AML Guillermo Garcia-Manero
NOVEL THERAPIES FOR MANTLE CELL LYMPHOMA Michael Wang
CP-4055, A NOVEL NUCELOSIDE ANALOG Frank J. Giles
NILOTINIB: A HIGHLY SPECIFIC BCR-ABL INHIBITOR Frank J. Giles
ROLE OF INTRAPERITONEAL DRUG DELIVERY IN THE MANAGEMENT OF OVARIAN CANCER Maurie Markman
BIOMARKERS FOR OVARIAN CANCER Robert C Bast
LAPATINIB/PACLITAXEL FOR INFLAMMATORY BREAST CANCER Massimo Cristofanilli
RECENT CHANGES IN INCIDENCE AND MORTALITY IN THE US Peter Ravdin
PHASE II STUDY OF RAD001 (EVEROLIMUS) AND DEPOT OCTREOTIDE IN ADVANCED LOW GRADE NEUROENDOCRINE CARCINOMA Alexandria Phan
BEVACIZUMAB FOR MALIGNANT GLIOMAS: RESULTS AND FUTURE DIRECTIONS Mark R. Gilbert
RANDOMIZED PHASE II TRIAL OF PACLITAXEL WITH OR WITHOUT STA 4783 IN METASTATIC MELANOMA David Lawson
RANDOMIZED PHASE II TRIAL OF PACLITAXEL WITH OR WITHOUT STA 4783 IN METASTATIC MELANOMA David Lawson
October 28, 2007 Third Annual Integrating Novel Agents With Radiotherapy in the Treatment of Solid Tumors Conference Integration of Angiogenesis Inhibition With RT Christopher Crane
October 20, 2007 Fourth Annual Fall Oncology Conference Role of RT In the Management of Lung Cancer Hak Choy
Special Topic: Update on the Current Management of Ovarian Cancer Maurie Markman
October 16, 2007 Inaugural HDAC inhibitors: Meeting the Challenges of Chemical Development of HDAC Inhibitors Oct (16 -17) MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT(11:10-16:30) Madeleine Duvic
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Panel Discussion- Are HDAC Inhibitors Proving Their Worth in the Clinic? (14:25-15:25) Madeleine Duvic
October 11, 2007 Sixth International Colorectal Cancer Congress Role of uPAR in Colorectal Cancer Lee M Ellis
Unexpected Findings in Angiogenesis Research Lee M Ellis
Should Anti-VEGF Therapy Continue Beyond Progession? Lee M Ellis
Angiopoietin Inhibitors Chris H. Takimoto
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.